mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
3e-05 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.17 |
7e-05 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |